MS sherpa receives an investment of 1.5 million euros
We are pleased to announce that MS sherpa receives an investment of 1.5 million euros. With the new capital, Sherpa BV will continue to grow independently as a start-up in the Netherlands and Germany and develop a new product and apply it to Parkinson’s disease.
The new investment round was supervised by startup investor Healthy.Capital. The capital comes from various private investors and our strategic partner CbusineZ. MS Sherpa also remains independent with this investment and collaborates with various clinics and academic partners for an academic approach. In addition, Orikami will remain involved as a development partner.
Read more in the press release.